Medtronic Lawsuit

In addition to concerns over the SprintFidelis leads in Medtronic’s internal defibrillator breaking at a rate higher than expected, now they may not actually detect problems accurately enough to deliver a shock when one is needed and the leads haven’t actually been broken. In addition to not delivering a shock when it’s needed, these poor sensors may deliver a shock even one isn’t needed.

A report by a Deutsch Bank analyst who was reporting on the impact of the recall of the Medtronic leads also speaks of reports that say the leads are not very good at sensing in general. The reports came from clinician contacts of Deutsche Bank but could still appear in medical reports.

The Medtronic SprintFidelis leads were designed to replace the Sprint Quattro leads. Until their recall in October, the SprintFidelis leads were the thinnest leads on the market. They were used in 90% of all Medtronic Defibrillator implantations since their release in 2004. The leads have  been tied to 5 deaths due to the fracture of leads so far.

The company last week announced not so stellar financial numbers. Sales in their heart rhythm management division are down $130 million. The company also had to write-off $30 million from the recalled leads.

If you or someone you know has been implanted with a Medtronic defibrillator featuring SprintFidelis leads and have experienced painful shocks at odd times, there may legal options available. Contact the Medtronic lawsuit attorneys of Williams Kherkher at 1-866-950-9000 to discuss these legal options and to schedule an initial consultation.